Crinetics Pharmaceuticals (CRNX) Treasury Shares (2025 - 2026)
Crinetics Pharmaceuticals' quarterly Treasury Shares came in at $1.0 million in Q1 2026, up 821.43% quarter-over-quarter from $112000.0 in Q4 2025.
Crinetics Pharmaceuticals has reported Treasury Shares for 2 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (changed N/A YoY), and the FY2025 full-year result was $112000.0, changed N/A from the prior year.
- Treasury Shares for Q1 2026 stood at $1.0 million, up from $112000.0 in the prior quarter.
- The five-year high for Treasury Shares was $1.0 million in Q1 2026, with the low at $112000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 112,000.00 |
| Dec 31, 2025 | 112,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 112,000.00 |